home / stock / govxw / govxw quote
Last: | $0.0918 |
---|---|
Change Percent: | 0.0% |
Open: | $0.1 |
Close: | $0.0918 |
High: | $0.104 |
Low: | $0.071 |
Volume: | 10,939 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.0918 | $0.1 | $0.0918 | $0.104 | $0.071 | 10,939 | 07-04-2024 |
$0.0918 | $0.1 | $0.0918 | $0.104 | $0.071 | 10,939 | 07-03-2024 |
$0.1195 | $0.1195 | $0.1195 | $0.1195 | $0.1195 | 786 | 07-02-2024 |
$0.121 | $0.13 | $0.121 | $0.135 | $0.1185 | 14,033 | 07-01-2024 |
$0.135 | $0.1997 | $0.135 | $0.227 | $0.1164 | 67,035 | 06-28-2024 |
$0.17 | $0.0472 | $0.17 | $0.2079 | $0.0472 | 209,289 | 06-27-2024 |
$0.0499 | $0.0471 | $0.0499 | $0.05 | $0.0471 | 4,753 | 06-26-2024 |
$0.0451 | $0.0646 | $0.0451 | $0.074 | $0.045 | 49,602 | 06-25-2024 |
$0.0885 | $0.0594 | $0.0885 | $0.0899 | $0.0569 | 49,999 | 06-24-2024 |
$0.0593 | $0.0995 | $0.0593 | $0.1108 | $0.0461 | 137,629 | 06-21-2024 |
$0.0989 | $0.22 | $0.0989 | $0.6 | $0.0606 | 441,467 | 06-20-2024 |
$0.0532 | $0.0302 | $0.0532 | $0.0564 | $0.0302 | 44,937 | 06-19-2024 |
$0.0532 | $0.0302 | $0.0532 | $0.056449 | $0.0302 | 44,937 | 06-18-2024 |
$0.0268 | $0.0355 | $0.0268 | $0.0355 | $0.0268 | 15,400 | 06-17-2024 |
$0.0364 | $0.0355 | $0.0364 | $0.0364 | $0.0355 | 200 | 06-13-2024 |
$0.0375 | $0 | $0.0375 | $0 | $0 | 19 | 06-04-2024 |
$0.0375 | $0.0352 | $0.0375 | $0.0375 | $0.0351 | 1,399 | 06-03-2024 |
$0.04 | $0.04 | $0.04 | $0.04 | $0.04 | 192 | 05-30-2024 |
$0.045 | $0.045 | $0.045 | $0.045 | $0.045 | 608 | 05-29-2024 |
$0.035 | $0.06 | $0.035 | $0.06 | $0.035 | 9,744 | 05-28-2024 |
News, Short Squeeze, Breakout and More Instantly...
GeoVax Labs Inc. Warrants Company Name:
GOVXW Stock Symbol:
NASDAQ Market:
GeoVax Labs Inc. Warrants Website:
Presentation Made During the 24th Annual World Vaccine Congress ATLANTA, GA, April 04, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced ...
ATLANTA, GA, March 28, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that its Chief Scientific Officer, Mark Newman, PhD, will presen...
ATLANTA, GA, March 12, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, announced today that its Chairman and CEO, David Dodd, will present at the 36t...